Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | HTT | P42858 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | G6PD | P11413 | 1/20 | 0.37 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.37 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.37 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.37 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7212732 | 0.82 | KMT2A (0.51) | KMT2AMEN1HTTL3MBTL1MAPT | |
| SCHEMBL5715738 | 0.78 | KMT2A (0.51) | KMT2AMEN1HTTL3MBTL1MAPT | |
| SCHEMBL2211499 | 0.77 | ALDH1A1 (0.41) | KMT2AMEN1HTTL3MBTL1MAPT | |
| SCHEMBL9226868 | 0.76 | MAPT (0.63) | KMT2AMEN1MAPTALDH1A1KDM4E | |
| SCHEMBL14259711 | 0.75 | KMT2A (0.60) | KMT2AMEN1HTTL3MBTL1MAPT | |
| SCHEMBL14754995 | 0.75 | KMT2A (0.62) | KMT2AMEN1HTTL3MBTL1MAPT | |
| SCHEMBL8994715 | 0.73 | KMT2A (0.49) | KMT2AMEN1HTTL3MBTL1MAPT | |
| SCHEMBL5572022 | 0.73 | KMT2A (0.50) | KMT2AMEN1HTTL3MBTL1MAPT | |
| SCHEMBL7809791 | 0.73 | MAPT (0.50) | KMT2AMEN1MAPTALDH1A1KDM4E | |
| SCHEMBL6130221 | 0.72 | KMT2A (0.62) | KMT2AMEN1HTTL3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1801093-B1 | Process for the Preparation of enantiomer-enriched 2-Alkoxy-3-Phenyl-Propionic Acid | SALTIGO GMBH (DE) | 2009-03-18 | — | — | EP | claimed |
| US-7429676-B2 | Process for preparing enantiomerically enriched 2-alkoxy-3-phenylpropionic acids | SALTIGO GMBH (DE) | 2008-09-30 | — | — | US | claimed |
| US-20070149804-A1 | Process for preparing enantiomerically enriched 2-alkoxy-3-phenylpropionic acids | SALTIGO GMBH (DE) | 2007-06-28 | — | — | US | claimed |
| US-7429676-B2 | Process for preparing enantiomerically enriched 2-alkoxy-3-phenylpropionic acids | SALTIGO GMBH (DE) | 2008-09-30 | — | — | US | disclosed |
| US-20070149804-A1 | Process for preparing enantiomerically enriched 2-alkoxy-3-phenylpropionic acids | SALTIGO GMBH (DE) | 2007-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070149804-A1 | Process for preparing enantiomerically enriched 2-alkoxy-3-phenylpropionic acids | HPD, PAH, APEH | KMT2A 1195/4885MEN1 3814/4885HTT 883/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.